Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2026-01-05 @ 1:21 PM
Study NCT ID:
NCT01933568
Status:
COMPLETED
Last Update Posted:
2019-06-27
First Post:
2013-08-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.
Sponsor:
The Netherlands Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-11
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-28
First Submit QC Date:
None
Study First Post Date:
2013-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-26
Last Update Post Date:
2019-06-27
Last Update Post Date Type:
ACTUAL